ImportRefusal LogoImportRefusal

The Sidhpur Sat-Isabgol Factory

⚠️ Moderate Risk

FEI: 3004256808 • Sidhpur, Gujarat • INDIA

FEI

FEI Number

3004256808

📍

Location

Sidhpur, Gujarat

🇮🇳

Country

INDIA
🏢

Address

Plot No. 503 State Highway, Near Khali Cross Road, Sidhpur, Gujarat, India

Moderate Risk

FDA Import Risk Assessment

43.6
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

9
Total Refusals
10
Unique Violations
12/12/2024
Latest Refusal
8/14/2012
Earliest Refusal

Score Breakdown

Violation Severity
47.2×40%
Refusal Volume
37.0×30%
Recency
64.2×20%
Frequency
7.3×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

23005×

DIETARYLBL

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it is a dietary supplement that appears to be misbranded within the meaning of Section 403(s)(2)(B) of the FD&C Act in that the label or labeling fails to identify the product by using the term "dietary supplement", which term may be modified with the name of such an ingredient.

2184×

LIST INGRE

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(i)(2) of the FD&C Act in that it is fabricated from two or more ingredients and the label fails to bear the common or usual name of each such ingredient and/or the article purports to be a beverage containing vegetable or fruit juice, but does not bear a statement with appropriate prominence on the information panel of the total percentage of such fruit or vegetable juice contained in the food.

754×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

4823×

NUTRIT LBL

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be misbranded in that the label or labeling fails to bear the required nutrition information.

36812×

NCONTACTS

The product is a dietary supplement that is marketed in the United States and appears to not have a domestic address or domestic phone number through which the responsible person may receive a report of a serious adverse event.

3242×

NO ENGLISH

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(f) of the FD&C Act in that any word, statement, or other information required by or under the authority of the FD&C Act to appear on the label or labeling is not prominently placed thereon with such conspicuousness (as compared with other words, statements, designs, or devices, in the labeling) and in such terms as to render it likely to be read and understood by the ordinary individual under customary terms of purchase and use (for example, label contains information in two or more languages but fails to repeat all required information in both languages in accordance with 21 CFR 101.15(c)(2), or label fails to include all required information in English in accordance with 21 CFR 101.15(c)(1), except in the case of articles distributed solely in the Commonwealth of Puerto Rico or in a Territory where the predominant language is one other than English)).

38642×

NCONTACT

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it is a dietary supplement that appears to be misbranded within the meaning of Section 403(y) of the FD&C Act in that the dietary supplement label fails to bear a domestic address or phone number through which the responsible person (as described in section 761 of the FD&C Act) may receive a report of a serious adverse event with such dietary supplement.

4731×

LABELING

The article appears in violation of FPLA because of its placement, form and/or contents statement.

1181×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

2561×

INCONSPICU

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(f) of the FD&C Act in that any word, statement, or other information required by or under the authority of the FD&C Act to appear on the label or labeling is not prominently placed thereon with such conspicuousness (as compared with other words, statements, designs, or devices, in the labeling) and in such terms as to render it likely to be read and understood by the ordinary individual under customary terms of purchase and use (for example, label contains information in two or more languages but fails to repeat all required information in both languages in accordance with 21 CFR 101.15(c)(2), or label fails to include all required information in English in accordance with 21 CFR 101.15(c)(1), except in the case of articles distributed solely in the Commonwealth of Puerto Rico or in a Territory where the predominant language is one other than English)).

Refusal History

DateProductViolationsDivision
12/12/2024
66VCY99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)
10/18/2019
54IBT02PSYLLIUM (FIBER)
218LIST INGRE
2300DIETARYLBL
3864NCONTACT
482NUTRIT LBL
Division of Northern Border Imports (DNBI)
10/18/2019
54IBT02PSYLLIUM (FIBER)
218LIST INGRE
2300DIETARYLBL
3864NCONTACT
473LABELING
482NUTRIT LBL
Division of Northern Border Imports (DNBI)
8/6/2019
60QDY07LIDOCAINE
118NOT LISTED
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/15/2014
62KAR99ANTI-PERISTALTIC N.E.C.
75UNAPPROVED
Los Angeles District Office (LOS-DO)
9/15/2014
62KAR99ANTI-PERISTALTIC N.E.C.
75UNAPPROVED
Los Angeles District Office (LOS-DO)
9/11/2012
54IDT02PSYLLIUM (FIBER)
218LIST INGRE
2300DIETARYLBL
324NO ENGLISH
3681NCONTACTS
Chicago District Office (CHI-DO)
9/11/2012
54IDT02PSYLLIUM (FIBER)
218LIST INGRE
2300DIETARYLBL
324NO ENGLISH
3681NCONTACTS
Chicago District Office (CHI-DO)
8/14/2012
54IGT02PSYLLIUM (FIBER)
2300DIETARYLBL
256INCONSPICU
482NUTRIT LBL
San Francisco District Office (SAN-DO)

Frequently Asked Questions

What is The Sidhpur Sat-Isabgol Factory's FDA import refusal history?

The Sidhpur Sat-Isabgol Factory (FEI: 3004256808) has 9 FDA import refusal record(s) in our database, spanning from 8/14/2012 to 12/12/2024.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. The Sidhpur Sat-Isabgol Factory's FEI number is 3004256808.

What types of violations has The Sidhpur Sat-Isabgol Factory received?

The Sidhpur Sat-Isabgol Factory has been cited for 10 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about The Sidhpur Sat-Isabgol Factory come from?

All FDA import refusal data for The Sidhpur Sat-Isabgol Factory is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.